ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline KNOT Offshore Partners Q4 2025 Earnings Significant EPS Miss Amid Challenging Market Conditions BVN Q4 2025 Earnings Massive EPS Beat of 122 Driven by Strong Operational Performance DRH Q1 2026 Earnings Strong EPS Beat Amidst Operational Discipline BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline